Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 22: 1262-1268, 1976;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cawley, L.
Right arrow Articles by Chelle, C
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cawley, L.
Right arrow Articles by Chelle, C

Clinical Chemistry, Vol 22, 1262-1268, Copyright © 1976 by American Association for Clinical Chemistry

Immunofixation electrophoretic techniques applied to identification of proteins in serum and cerebrospinal fluid

LP Cawley, BJ Minard, WW Tourtellotte, BI Ma and C Chelle

We describe the application of immunofixation staining of agarose-gel electrophoretograms in areas where its use in the clinical laboratory is appropriate. Immunofixation electrophoresis consists of an electrophoretic phase followed by a fixation phase in which antiserum is used to precipitate the protein. As long as the antibody is in slight excess or near equivalency, the antigen/antibody complex remains insoluble. The reaction can be detected by visual inspection in indirect light, by protein staining, or by use of antibodies labeled with fluorescein, enzyme, or isotope. In the method described here we primarily have used protein staining (Coomassie Blue) to accentuate the proteins fixed by antisera. All unreacted proteins are removed by pressing with filter paper and saline washing. In the clinical laboratory, this method expedites immunochemical evaluation of samples and may also supplement immunoelectrophoresis. It has been applied successfully in identifying small obscure monoclonal proteins in the serum and cerebrospinal fluid of patients with multiple sclerosis, subacute sclerosing panencephalitis, biclonal gammopathies, serum monoclonal light chains, and mobility shifts of certain proteins, particularly of the complement series. Immunofixation demonstrates that the protein bands present in spinal fluid from multiple sclerosis and subacute sclerosing panencephalitis patients are of the IgG class of immunoglobulins; and non-IgG protein, such as beta and gamma trace proteins, are not detected. We also comment on reverse immunofixation with labeled antigen as a branch of the procedure that allows detection of function of the immunoglobulins separated by electrophoresis.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. Attaelmannan and S. S. Levinson
Understanding and Identifying Monoclonal Gammopathies
Clin. Chem., August 1, 2000; 46(8): 1230 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. J. Zuckerman, M. A. Pesce, L. P. Rowland, W. Sherman, M. E. Shy, N. Latov, and E. F. Osserman
An Alert for Motor Neuron Diseases and Peripheral Neuropathy: Monoclonal Paraproteinemia May Be Missed by Routine Electrophoresis
Arch Neurol, March 1, 1987; 44(3): 250 - 251.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
A. A. Keshgegian
Oligoclonal Bands in Myoclonus Epilepsy
Arch Neurol, May 1, 1982; 39(5): 321 - 321.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
W. W. Tourtellotte, A. R. Potvin, R. W. Baumhefner, J. H. Potvin, B. I. Ma, K. Syndulko, and Z. Petrovich
Multiple Sclerosis De Novo CNS IgG Synthesis: Effect of CNS Irradiation
Arch Neurol, October 1, 1980; 37(10): 620 - 624.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by the American Association for Clinical Chemistry.